个人中心 - 老虎社区

OldCitron

IP属地：未知

帖子 · 3帖子 · 3
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- OldCitronOldCitron
  ·2021-12-23
  Read
  Netflix Stock: Why It Might Outperform Rivals in 2022
  Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outper
  Netflix Stock: Why It Might Outperform Rivals in 2022
  990 评论
  点赞
  分享
  举报
- OldCitronOldCitron
  ·2021-11-18
  👍
  Toplines Before US Market Open on Thursday
  U.S. jobless claims total 268,000, about as expected.Stock-index futures remain slightly higher afte
  Toplines Before US Market Open on Thursday
  1,071 2
  3
  分享
  举报
- OldCitronOldCitron
  ·2021-11-02
  👍
  Novavax shares jumped another 4.4% in premarket trading
  Novavax shares jumped another 4.4% in premarket trading Tuesday after rising nearly 16% yesterday as
  Novavax shares jumped another 4.4% in premarket trading
  1,087 评论
  4
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3571555251496435","uuid":"3571555251496435","gmtCreate":1608461453498,"gmtModify":1635220150899,"name":"OldCitron","pinyin":"oldcitron","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/19642cef76c55c41de70d3d33a39db1c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":56,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.29","exceedPercentage":"93.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.72%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691705617,"gmtCreate":1640237216078,"gmtModify":1640237216078,"author":{"id":"3571555251496435","authorId":"3571555251496435","name":"OldCitron","avatar":"https://static.tigerbbs.com/19642cef76c55c41de70d3d33a39db1c","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571555251496435","authorIdStr":"3571555251496435"},"themes":[],"htmlText":"Read","listText":"Read","text":"Read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691705617","repostId":"1132132037","repostType":4,"repost":{"id":"1132132037","kind":"news","pubTimestamp":1640236963,"share":"https://www.laohu8.com/m/news/1132132037?lang=&edition=full","pubTime":"2021-12-23 13:22","market":"us","language":"en","title":"Netflix Stock: Why It Might Outperform Rivals in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1132132037","media":"TheStreet","summary":"Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outper","content":"<p>Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.</p>\n<p>After Netflix's&nbsp;great stock performance in 2021, fans of the streaming service are wondering what's in store for the company and its shares in 2022.</p>\n<p>Let's sum up what happened to NFLX shares this year and whether they still present a good opportunity for investors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a2b3cf4fdc5d06fd34521575cb3c69b3\" tg-width=\"1240\" tg-height=\"812\" width=\"100%\" height=\"auto\"><span>Figure 1: Netflix's office.</span></p>\n<p><b>Netflix's 2021 Revenue Results</b></p>\n<p>Looking at company revenue, Netflix continued to grow during 2021 but experienced a slowdown compared to 2020. This was likely due to the subscription boom the company experienced during 2020 thanks to COVID lockdowns.</p>\n<p>Even so, during the last three quarters, Netflix's revenue showed year-over-year average revenue growth of 20%. In addition, its operating margins rose from 20.4% in the third quarter of 2020 to 23.5% in the third quarter of 2021.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f704b36024b940ec42ace68116770a9\" tg-width=\"949\" tg-height=\"438\" width=\"100%\" height=\"auto\"><span>Figure 2: Netflix's financial statements.</span></p>\n<p>Subscriber growth is another key metric for investors. Unfortunately, results here were disappointing in 2021.</p>\n<p>In 2020, Netflix's subscriber growth was more than 20% per quarter. This dropped to 10% in 2021.</p>\n<p>However, investors should take it into account that, during the early months of the pandemic, the company experienced record-breaking growth. The decrease we've seen this year may just be the result of subscriber growth returning to normal levels.</p>\n<p><b>How Did NFLX Perform Against Other Streaming Services?</b></p>\n<p>Compared to its competitors, NFLX did very well in 2021 with cumulative growth of 16%. Other stocks that compete in the video streaming segment saw worse returns. For example, Amazon&nbsp;shares appreciated only 5%, while Disney&nbsp;suffered a drop of nearly 20%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd970e1a30a0271380825554f364907d\" tg-width=\"811\" tg-height=\"428\" width=\"100%\" height=\"auto\"><span>Figure 3: AMZN, DIS, NFLX and SPY performance in 2021.</span></p>\n<p>However, NFLX's performance looks less stellar when compared to companies outside the streaming segment. In fact, the stock underperformed the S&amp;P 500 in 2021.</p>\n<p>As Netflix stock moves away from its peak in November, there may still be room for the company to grow.</p>\n<p><b>What's Next?: Our Take on NFLX for 2022</b></p>\n<p>Netflix was a pioneer in the video streaming segment. And despite fierce competition from giants like Disney and Amazon, it still has the largest market share in the industry.</p>\n<p>In addition, Netflix is constantly betting on new segments for revenue growth. For example, it recently pushed beyond films by launching an interactive games division. Moves like this expose Netflix to new subscribers and boost its bottom line.</p>\n<p>We believe that the recent fall in NFLX’s stock price translates to a buying opportunity for long-term investors who agree there’s still plenty of growth to come.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Stock: Why It Might Outperform Rivals in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Stock: Why It Might Outperform Rivals in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 13:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.\nAfter Netflix's great stock performance in 2021, fans of the ...</p>\n\n<a href=\"https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.thestreet.com/streaming/nflx/netflix-stock-should-you-buy-nflx-shares-in-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132132037","content_text":"Could 2022 be a great year for Netflix stock? Here's why shares of the streaming platform may outperform its competitors again next year.\nAfter Netflix's great stock performance in 2021, fans of the streaming service are wondering what's in store for the company and its shares in 2022.\nLet's sum up what happened to NFLX shares this year and whether they still present a good opportunity for investors.\nFigure 1: Netflix's office.\nNetflix's 2021 Revenue Results\nLooking at company revenue, Netflix continued to grow during 2021 but experienced a slowdown compared to 2020. This was likely due to the subscription boom the company experienced during 2020 thanks to COVID lockdowns.\nEven so, during the last three quarters, Netflix's revenue showed year-over-year average revenue growth of 20%. In addition, its operating margins rose from 20.4% in the third quarter of 2020 to 23.5% in the third quarter of 2021.\nFigure 2: Netflix's financial statements.\nSubscriber growth is another key metric for investors. Unfortunately, results here were disappointing in 2021.\nIn 2020, Netflix's subscriber growth was more than 20% per quarter. This dropped to 10% in 2021.\nHowever, investors should take it into account that, during the early months of the pandemic, the company experienced record-breaking growth. The decrease we've seen this year may just be the result of subscriber growth returning to normal levels.\nHow Did NFLX Perform Against Other Streaming Services?\nCompared to its competitors, NFLX did very well in 2021 with cumulative growth of 16%. Other stocks that compete in the video streaming segment saw worse returns. For example, Amazon shares appreciated only 5%, while Disney suffered a drop of nearly 20%.\nFigure 3: AMZN, DIS, NFLX and SPY performance in 2021.\nHowever, NFLX's performance looks less stellar when compared to companies outside the streaming segment. In fact, the stock underperformed the S&P 500 in 2021.\nAs Netflix stock moves away from its peak in November, there may still be room for the company to grow.\nWhat's Next?: Our Take on NFLX for 2022\nNetflix was a pioneer in the video streaming segment. And despite fierce competition from giants like Disney and Amazon, it still has the largest market share in the industry.\nIn addition, Netflix is constantly betting on new segments for revenue growth. For example, it recently pushed beyond films by launching an interactive games division. Moves like this expose Netflix to new subscribers and boost its bottom line.\nWe believe that the recent fall in NFLX’s stock price translates to a buying opportunity for long-term investors who agree there’s still plenty of growth to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":990,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876015943,"gmtCreate":1637244042435,"gmtModify":1637244042435,"author":{"id":"3571555251496435","authorId":"3571555251496435","name":"OldCitron","avatar":"https://static.tigerbbs.com/19642cef76c55c41de70d3d33a39db1c","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571555251496435","authorIdStr":"3571555251496435"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876015943","repostId":"1164154545","repostType":4,"repost":{"id":"1164154545","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637242506,"share":"https://www.laohu8.com/m/news/1164154545?lang=&edition=full","pubTime":"2021-11-18 21:35","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1164154545","media":"Tiger Newspress","summary":"U.S. jobless claims total 268,000, about as expected.Stock-index futures remain slightly higher afte","content":"<p>U.S. jobless claims total 268,000, about as expected.Stock-index futures remain slightly higher after weekly jobless claims.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 25 points, or 0.07%. S&amp;P 500 e-minis were up 11.5 points, or 0.24% and Nasdaq 100 e-minis were up 81.5 points, or 0.5%.</p>\n<p><img src=\"https://static.tigerbbs.com/c2323335c4b6a87d86114934b4851738\" tg-width=\"401\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Nvidia(NVDA)</b> – Nvidia came in 6 cents above estimates with adjusted quarterly earnings of $1.17 per share, and the graphics chip maker saw revenue come in above forecasts as well. Nvidia is benefiting from high demand for videogame and data center chips. The stock jumped 8.2% in the premarket.</p>\n<p><b>Alibaba(BABA)</b> – The Chinese e-commerce giant slid 6.4% in premarket action after top- and bottom-line misses in its latest quarterly report. Alibaba is attributing the drop in profit from a year ago to a decline in the value of its equity investments.</p>\n<p><b>JD.com(JD)</b> – JD.com beat estimates on both the top and bottom lines with the China-based e-commerce company continuing to benefit from sustained and elevated demand for online shopping. Shares rose 3% in the premarket.</p>\n<p><b>Macy’s(M)</b> – Macy’s surged 11.1% in the premarket after the retailer reported better-than-expected quarterly sales and profit, and raised its full-year outlook. Macy’s earned an adjusted $1.23 per share for the quarter, well above the 31-cent consensus estimate, and the raised forecast is easing concern about holiday season inventory shortages.</p>\n<p><b>Roblox(RBLX)</b>&nbsp;–&nbsp;Morgan Stanley raised its price target on Roblox to $150 per share from $88. The new target is 20% above where the stock closed Wednesday and is the highest among major Wall Street firms, according to FactSet. Shares rose nearly 4% in premarket trading Thursday.</p>\n<p><b>BJ’s Wholesale(BJ) </b>– The warehouse retailer beat estimates by 11 cents with adjusted quarterly earnings of 91 cents per share, while revenue and comparable-store sales also topped forecasts. BJ’s also announced a new stock buyback program worth up to $500 million.The&nbsp;shares&nbsp;rose&nbsp;6.1%&nbsp;in the premarket.</p>\n<p><b>Kohl’s(KSS)</b> – Kohl’s rallied 8.5% in premarket trading as the retailer reported adjusted quarterly earnings of $1.65 per share compared with a consensus estimate of 64 cents. Kohl’s also reported better-than-expected revenue and comparable store sales, and raised its full-year sales forecast.</p>\n<p><b>Petco(WOOF)</b> – The pet products retailer beat estimates by 2 cents with adjusted quarterly earnings of 20 cents per share and revenue also above estimates. Comparable store sales were also better than expected, and Petco raised its full-year forecast.</p>\n<p><b>Cisco Systems(CSCO)</b> – Cisco tumbled 6.8% in premarket trading after forecasting current-quarter revenue below forecasts. The networking equipment company is seeing supply chain and other issues driving up costs. Cisco did report better-than-expected earnings for its most recent quarter, but revenue was slightly short of Wall Street forecasts.</p>\n<p><b>Sonos(SONO)</b> – Sonos matched estimates in reporting a quarterly loss of 7 cents per share, but the maker of wireless home audio equipment saw revenue come in slightly below analyst projections. However, Sonos also issued a better-than-expected fiscal 2022 sales forecast, even in the face of supply constraints that are impacting its production levels, and the stock added 3.6% in premarket action.</p>\n<p><b>Bath &amp; Body Works(BBWI)</b> – Bath &amp; Body Works reported an adjusted quarterly profit of 92 cents per share, beating the 60 cents consensus estimate, while the personal care products retailer also saw revenue beat Wall Street forecasts. The quarterly report was the first for Bath &amp; Body Works as a standalone company following the split-up of L Brands. The stock gained 6.4% in premarket trading.</p>\n<p><b>Victoria’s Secret(VSCO)</b> – Victoria’s Secret shares surged 10.9% in premarket trading after the company beat estimates by 10 cents with adjusted quarterly earnings of 81 cents per share. This was the first quarterly report for Victoria’s Secret as a standalone company, also a product of the L Brands split-up.</p>\n<p><b>Deere(DE)</b> – Deere workers approved a new six-year contract after rejecting two previous tentative deals, ending a strike that began October 14. Deere rose 2.4% in the premarket.</p>\n<p><b>Maxeon Solar Technologies(MAXN)</b>&nbsp;–&nbsp;U.S.-listed shares of Singapore-based Maxeon Solar Technologies fell 10% as the solar technology company forecast dismal fourth-quarter revenue after posting downbeat quarterly earnings.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-18 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. jobless claims total 268,000, about as expected.Stock-index futures remain slightly higher after weekly jobless claims.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 25 points, or 0.07%. S&amp;P 500 e-minis were up 11.5 points, or 0.24% and Nasdaq 100 e-minis were up 81.5 points, or 0.5%.</p>\n<p><img src=\"https://static.tigerbbs.com/c2323335c4b6a87d86114934b4851738\" tg-width=\"401\" tg-height=\"184\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Nvidia(NVDA)</b> – Nvidia came in 6 cents above estimates with adjusted quarterly earnings of $1.17 per share, and the graphics chip maker saw revenue come in above forecasts as well. Nvidia is benefiting from high demand for videogame and data center chips. The stock jumped 8.2% in the premarket.</p>\n<p><b>Alibaba(BABA)</b> – The Chinese e-commerce giant slid 6.4% in premarket action after top- and bottom-line misses in its latest quarterly report. Alibaba is attributing the drop in profit from a year ago to a decline in the value of its equity investments.</p>\n<p><b>JD.com(JD)</b> – JD.com beat estimates on both the top and bottom lines with the China-based e-commerce company continuing to benefit from sustained and elevated demand for online shopping. Shares rose 3% in the premarket.</p>\n<p><b>Macy’s(M)</b> – Macy’s surged 11.1% in the premarket after the retailer reported better-than-expected quarterly sales and profit, and raised its full-year outlook. Macy’s earned an adjusted $1.23 per share for the quarter, well above the 31-cent consensus estimate, and the raised forecast is easing concern about holiday season inventory shortages.</p>\n<p><b>Roblox(RBLX)</b>&nbsp;–&nbsp;Morgan Stanley raised its price target on Roblox to $150 per share from $88. The new target is 20% above where the stock closed Wednesday and is the highest among major Wall Street firms, according to FactSet. Shares rose nearly 4% in premarket trading Thursday.</p>\n<p><b>BJ’s Wholesale(BJ) </b>– The warehouse retailer beat estimates by 11 cents with adjusted quarterly earnings of 91 cents per share, while revenue and comparable-store sales also topped forecasts. BJ’s also announced a new stock buyback program worth up to $500 million.The&nbsp;shares&nbsp;rose&nbsp;6.1%&nbsp;in the premarket.</p>\n<p><b>Kohl’s(KSS)</b> – Kohl’s rallied 8.5% in premarket trading as the retailer reported adjusted quarterly earnings of $1.65 per share compared with a consensus estimate of 64 cents. Kohl’s also reported better-than-expected revenue and comparable store sales, and raised its full-year sales forecast.</p>\n<p><b>Petco(WOOF)</b> – The pet products retailer beat estimates by 2 cents with adjusted quarterly earnings of 20 cents per share and revenue also above estimates. Comparable store sales were also better than expected, and Petco raised its full-year forecast.</p>\n<p><b>Cisco Systems(CSCO)</b> – Cisco tumbled 6.8% in premarket trading after forecasting current-quarter revenue below forecasts. The networking equipment company is seeing supply chain and other issues driving up costs. Cisco did report better-than-expected earnings for its most recent quarter, but revenue was slightly short of Wall Street forecasts.</p>\n<p><b>Sonos(SONO)</b> – Sonos matched estimates in reporting a quarterly loss of 7 cents per share, but the maker of wireless home audio equipment saw revenue come in slightly below analyst projections. However, Sonos also issued a better-than-expected fiscal 2022 sales forecast, even in the face of supply constraints that are impacting its production levels, and the stock added 3.6% in premarket action.</p>\n<p><b>Bath &amp; Body Works(BBWI)</b> – Bath &amp; Body Works reported an adjusted quarterly profit of 92 cents per share, beating the 60 cents consensus estimate, while the personal care products retailer also saw revenue beat Wall Street forecasts. The quarterly report was the first for Bath &amp; Body Works as a standalone company following the split-up of L Brands. The stock gained 6.4% in premarket trading.</p>\n<p><b>Victoria’s Secret(VSCO)</b> – Victoria’s Secret shares surged 10.9% in premarket trading after the company beat estimates by 10 cents with adjusted quarterly earnings of 81 cents per share. This was the first quarterly report for Victoria’s Secret as a standalone company, also a product of the L Brands split-up.</p>\n<p><b>Deere(DE)</b> – Deere workers approved a new six-year contract after rejecting two previous tentative deals, ending a strike that began October 14. Deere rose 2.4% in the premarket.</p>\n<p><b>Maxeon Solar Technologies(MAXN)</b>&nbsp;–&nbsp;U.S.-listed shares of Singapore-based Maxeon Solar Technologies fell 10% as the solar technology company forecast dismal fourth-quarter revenue after posting downbeat quarterly earnings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164154545","content_text":"U.S. jobless claims total 268,000, about as expected.Stock-index futures remain slightly higher after weekly jobless claims.\nAt 8:34 a.m. ET, Dow e-minis were up 25 points, or 0.07%. S&P 500 e-minis were up 11.5 points, or 0.24% and Nasdaq 100 e-minis were up 81.5 points, or 0.5%.\n\nStocks making the biggest moves premarket:\nNvidia(NVDA) – Nvidia came in 6 cents above estimates with adjusted quarterly earnings of $1.17 per share, and the graphics chip maker saw revenue come in above forecasts as well. Nvidia is benefiting from high demand for videogame and data center chips. The stock jumped 8.2% in the premarket.\nAlibaba(BABA) – The Chinese e-commerce giant slid 6.4% in premarket action after top- and bottom-line misses in its latest quarterly report. Alibaba is attributing the drop in profit from a year ago to a decline in the value of its equity investments.\nJD.com(JD) – JD.com beat estimates on both the top and bottom lines with the China-based e-commerce company continuing to benefit from sustained and elevated demand for online shopping. Shares rose 3% in the premarket.\nMacy’s(M) – Macy’s surged 11.1% in the premarket after the retailer reported better-than-expected quarterly sales and profit, and raised its full-year outlook. Macy’s earned an adjusted $1.23 per share for the quarter, well above the 31-cent consensus estimate, and the raised forecast is easing concern about holiday season inventory shortages.\nRoblox(RBLX) – Morgan Stanley raised its price target on Roblox to $150 per share from $88. The new target is 20% above where the stock closed Wednesday and is the highest among major Wall Street firms, according to FactSet. Shares rose nearly 4% in premarket trading Thursday.\nBJ’s Wholesale(BJ) – The warehouse retailer beat estimates by 11 cents with adjusted quarterly earnings of 91 cents per share, while revenue and comparable-store sales also topped forecasts. BJ’s also announced a new stock buyback program worth up to $500 million.The shares rose 6.1% in the premarket.\nKohl’s(KSS) – Kohl’s rallied 8.5% in premarket trading as the retailer reported adjusted quarterly earnings of $1.65 per share compared with a consensus estimate of 64 cents. Kohl’s also reported better-than-expected revenue and comparable store sales, and raised its full-year sales forecast.\nPetco(WOOF) – The pet products retailer beat estimates by 2 cents with adjusted quarterly earnings of 20 cents per share and revenue also above estimates. Comparable store sales were also better than expected, and Petco raised its full-year forecast.\nCisco Systems(CSCO) – Cisco tumbled 6.8% in premarket trading after forecasting current-quarter revenue below forecasts. The networking equipment company is seeing supply chain and other issues driving up costs. Cisco did report better-than-expected earnings for its most recent quarter, but revenue was slightly short of Wall Street forecasts.\nSonos(SONO) – Sonos matched estimates in reporting a quarterly loss of 7 cents per share, but the maker of wireless home audio equipment saw revenue come in slightly below analyst projections. However, Sonos also issued a better-than-expected fiscal 2022 sales forecast, even in the face of supply constraints that are impacting its production levels, and the stock added 3.6% in premarket action.\nBath & Body Works(BBWI) – Bath & Body Works reported an adjusted quarterly profit of 92 cents per share, beating the 60 cents consensus estimate, while the personal care products retailer also saw revenue beat Wall Street forecasts. The quarterly report was the first for Bath & Body Works as a standalone company following the split-up of L Brands. The stock gained 6.4% in premarket trading.\nVictoria’s Secret(VSCO) – Victoria’s Secret shares surged 10.9% in premarket trading after the company beat estimates by 10 cents with adjusted quarterly earnings of 81 cents per share. This was the first quarterly report for Victoria’s Secret as a standalone company, also a product of the L Brands split-up.\nDeere(DE) – Deere workers approved a new six-year contract after rejecting two previous tentative deals, ending a strike that began October 14. Deere rose 2.4% in the premarket.\nMaxeon Solar Technologies(MAXN) – U.S.-listed shares of Singapore-based Maxeon Solar Technologies fell 10% as the solar technology company forecast dismal fourth-quarter revenue after posting downbeat quarterly earnings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1071,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843494112,"gmtCreate":1635847786040,"gmtModify":1635847786040,"author":{"id":"3571555251496435","authorId":"3571555251496435","name":"OldCitron","avatar":"https://static.tigerbbs.com/19642cef76c55c41de70d3d33a39db1c","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571555251496435","authorIdStr":"3571555251496435"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843494112","repostId":"1146954113","repostType":4,"repost":{"id":"1146954113","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635841327,"share":"https://www.laohu8.com/m/news/1146954113?lang=&edition=full","pubTime":"2021-11-02 16:22","market":"us","language":"en","title":"Novavax shares jumped another 4.4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1146954113","media":"Tiger Newspress","summary":"Novavax shares jumped another 4.4% in premarket trading Tuesday after rising nearly 16% yesterday as","content":"<p>Novavax shares jumped another 4.4% in premarket trading&nbsp;Tuesday&nbsp;after rising nearly 16% yesterday&nbsp;as&nbsp;Novavax COVID-19 vaccine got first authorization; expected more within weeks.</p>\n<p><img src=\"https://static.tigerbbs.com/93777ff8ed669db1e3ea1516ae6b0f1f\" tg-width=\"849\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p>\n<p>Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.</p>\n<p>The company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.</p>\n<p>For Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.</p>\n<p>The World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.</p>\n<p>A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.</p>\n<p>“I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.</p>\n<p>Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.</p>\n<p>He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”</p>\n<p>Novavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.</p>\n<p>SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.</p>\n<p>Indonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.</p>\n<p>Penny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.</p>\n<p>Novavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.</p>\n<p>“It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.</p>\n<p>The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.</p>\n<p>The Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares jumped another 4.4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares jumped another 4.4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 16:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares jumped another 4.4% in premarket trading&nbsp;Tuesday&nbsp;after rising nearly 16% yesterday&nbsp;as&nbsp;Novavax COVID-19 vaccine got first authorization; expected more within weeks.</p>\n<p><img src=\"https://static.tigerbbs.com/93777ff8ed669db1e3ea1516ae6b0f1f\" tg-width=\"849\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p>\n<p>Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.</p>\n<p>The company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.</p>\n<p>For Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.</p>\n<p>The World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.</p>\n<p>A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.</p>\n<p>“I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.</p>\n<p>Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.</p>\n<p>He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”</p>\n<p>Novavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.</p>\n<p>SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.</p>\n<p>Indonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.</p>\n<p>Penny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.</p>\n<p>Novavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.</p>\n<p>“It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.</p>\n<p>The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.</p>\n<p>The Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146954113","content_text":"Novavax shares jumped another 4.4% in premarket trading Tuesday after rising nearly 16% yesterday as Novavax COVID-19 vaccine got first authorization; expected more within weeks.\n\nNovavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.\nThe company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.\nFor Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.\nThe World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.\nA green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.\n“I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.\nErck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.\nHe said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”\nNovavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.\nSII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.\nIndonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.\nPenny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.\nNovavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.\n“It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.\nThe company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.\nThe Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1087,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}